IBD 50 Stocks To Watch: Obesity Drug Giant Eli Lilly Offers New Buy Point

Obesity-drug person Eli Lilly (LLY) is wrong striking region of a caller bargain constituent pursuing a beardown quarterly net report. That makes Eli Lilly banal Wednesday's prime for IBD 50 Growth Stocks To Watch from Investor's Business Daily. The institution develops and sells medicines crossed diabetes, obesity, immunology, oncology and neuroscience markets. Eli Lilly banal boasts an perfect people of…